| Document Date: 2014-06-02 10:50:45
Open Document File Size: 131,09 KBShare Result on Facebook
City Glenview / Tampa / Richmond / New York / / Company Orexo US Inc. / Reckitt Benckiser / Reckitt Benckiser Pharmaceuticals Inc. / Gold Standard Inc. / / Event Product Issues / Product Recall / / IndustryTerm Search terms / treatment of acute pain and cancer / / MedicalCondition opioid withdrawal symptoms / cancer / Patient allergy / allergy / pain / marked and intense withdrawal symptoms / / MedicalTreatment pain management / counseling / / Organization World Health Organization / American Pain Society / Substance Abuse and Mental Health Services Administration / / / Position Secretary of Health / physician / / Product Naloxone / Suboxone / symptoms / Subutex / Zubsolv 1.4 / PRIOR AUTHORIZATION POLICY Buprenorphine tablets / Zubsolv 5.7 / Buprenorphine 2 mg / Buprenorphine / Buprenorphine 8 mg / / URL http /
SocialTag |
PRIOR AUTHORIZATION POLICY Buprenorphine tablets and Buprenorphine/Naloxone tablets/films To Initiate a Coverage Review, Call[removed]DRUGS AFFECTED: Buprenorphine sublingual tablets (previously available as Subut